journal article·2021-04

Accelerating neovascularization and kidney tissue formation with a 3D vascular scaffold capturing native vascular structure

Sangil Min, David Cleveland, In Kap Ko, Ji Hyun Kim, Hee Jo Yang, Anthony Atala, James J. Yoo

Acta Biomaterialia· Volume 124
Publisher page

Abstract

Establishing an adequate vascularization of three-dimensional (3D) bioengineered tissues remains a critical challenge. We previously fabricated a vascular scaffold using the vascular corrosion casting technique, which provides a similar 3D geometry of native kidney vasculature. In this study, we functionalized the collagen vascular scaffold with a controlled release of vascular endothelial growth factor (VEGF vascular scaffold) to further promote vascularization. The VEGF vascular scaffold showed improved angiogenic capability in 2-dimensional (2D) and 3D in vitro settings. Implantation of the VEGF vascular scaffold seeded with human renal cells into a rat kidney demonstrated enhanced implant vascularization and reduced apoptosis of implanted human renal cells. Hybrid renal tubule-like structures composed of implanted human and migrated host renal cells were formed. This work highlights the critical role of early vascularization of the geometrically mimetic vascular scaffold using the VEGF incorporated vascular scaffold in reducing apoptosis of implanted cells as well as the formation of renal tissue structures.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (33)

Show source-provided references
1. Global prevalence of chronic kidney disease - a systematic review and meta-analysis10.1371/journal.pone.0158765 ↗
2. Chronic kidney disease: global dimension and perspectives10.1016/S0140-6736(13)60687-X ↗
3. Kidney disease, relation between kidney function, proteinuria, and adverse outcomes10.1001/jama.2010.39 ↗
4. Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease improving global outcomes10.1038/sj.ki.5002343 ↗
5. Has the incidence of end-stage renal disease in the USA and other countries stabilized?10.1097/MNH.0b013e3283454319 ↗
6. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection10.2165/11319260-000000000-00000 ↗
7. OPTN/SRTR 2016 Annual Data Report: Kidney10.1111/ajt.14557 ↗
8. A call for government accountability to achieve national self-sufficiency in organ donation and transplantation10.1016/S0140-6736(11)61486-4 ↗
9. Vascularization–the conduit to viable engineered tissues10.1089/ten.teb.2008.0193 ↗
10. Vascularization strategies for tissue engineering10.1089/ten.teb.2009.0085 ↗
11. Principals of neovascularization for tissue engineering10.1016/S0098-2997(02)00008-0 ↗
12. 3D Bioprinting for vascularized tissue fabrication10.1007/s10439-016-1653-z ↗
13. Cd31 antibody conjugation improves re-endothelialization of acellular kidney scaffolds for whole kidney engineering
14. Bioengineered transplantable porcine livers with re-endothelialized vasculature10.1016/j.biomaterials.2014.11.027 ↗
15. Fabrication of biomimetic vascular scaffolds for 3D tissue constructs using vascular corrosion casts10.1016/j.actbio.2016.01.005 ↗
16. Kidney regeneration with biomimetic vascular scaffolds based on vascular corrosion casts10.1016/j.actbio.2019.04.001 ↗
17. Controlled heparin conjugation on electrospun poly(epsilon-caprolactone)/gelatin fibers for morphology-dependent protein delivery and enhanced cellular affinity10.1016/j.actbio.2012.03.030 ↗
18. Combined systemic and local delivery of stem cell inducing/recruiting factors for in situ tissue regeneration10.1096/fj.11-182998 ↗
19. Potential use of autologous renal cells from diseased kidneys for the treatment of renal failure10.1371/journal.pone.0164997 ↗
20. Progress in the tissue engineering and stem cell industry "are we there yet?10.1089/ten.teb.2011.0553 ↗
21. Vascularization and angiogenesis in tissue engineering: beyond creating static networks10.1016/j.tibtech.2016.03.002 ↗
23. Fabrication of nature-inspired microfluidic network for perfusable tissue constructs10.1002/adhm.201200404 ↗
24. Additive manufacturing of biomedical constructs with biomimetic structural organizations10.3390/ma9110909 ↗
25. Addressing thrombogenicity in vascular graft construction10.1002/jbm.b.30710 ↗
26. Heparin-functionalized collagen matrices with controlled release of basic fibroblast growth factor10.1007/s10856-010-4176-4 ↗
27. In vitro and in vivo evaluation of a small-caliber coaxial electrospun vascular graft loaded with heparin and VEGF10.1016/j.ijsu.2017.06.077 ↗
28. Endothelial precursor cell migration during vasculogenesis10.1161/CIRCRESAHA.107.148932 ↗
29. Molecular regulation of angiogenesis and lymphangiogenesis10.1038/nrm2183 ↗
30. Extracellular matrix, inflammation, and the angiogenic response10.1093/cvr/cvq049 ↗
31. In vitro reconstitution of human kidney structures for renal cell therapy10.1093/ndt/gfr785 ↗
32. Generation of functioning nephrons by implanting human pluripotent stem cell-derived kidney progenitors10.1016/j.stemcr.2018.01.008 ↗
33. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure10.1681/ASN.2005070757 ↗